In order to increase manufacturing capacity and to supply materials smoother, we are planning to invest 14.5 billion won which is 19.14% of the capital in building a new manufacturing plant.

By applying the manufacturing process of the pharmaceutical companies, we plan to build an optimal hygienic environment and a tour line that shows the chain of manufacturing process to minimize

the number of defective products and to secure production transparency and accessibility.

We will do our best to manufacture trustworthy products with absolute hygiene management and smooth manufacturing at our new plant. Thank you.